| |
Original Artikel |
Datum |
Titel |
Autoren Alle Autoren |
| 1 |
[GO] |
2025―Jun―29 |
Diagnostic screening of COVID-19 based on multiomics data by high-resolution mass spectrometry (MALDI (+)-TOF MS and ESI(±)-Orbitrap MS) |
Camila Medeiros de Almeida, Larissa Campos Motta, Gabriely Silveira Folli, Juliana de Mello do Carmo, Andréa Rodrigues Chaves, José Brango-Vanegas, et al. (+8) Rosiane Andrade da Costa, Octavio Luiz Franco, Frederico Garcia Pinto, Denise Coutinho Endringer, Paulo Roberto Filgueiras, Valério Garrone Barauna, José Geraldo Mill, Wanderson Romão |
| 2 |
[GO] |
2025―Mai―21 |
Metabolic signature of COVID-19 progression: potential prognostic markers for severity and outcome |
Hien Thi Thu Nguyen, Malene Pontoppidan Stoico, Vang Quy Le, Jakob Holm Dalsgaard Thomsen, Kasper Bygum Krarup, Karoline Assifuah Kristjansen, et al. (+2) Inge Søkilde Pedersen, Henrik Bygum Krarup |
| 3 |
[GO] |
2025―Mai―07 |
Longitudinal lipoprotein and inflammatory mediators analysis uncover persisting inflammation and hyperlipidemia following SARS-CoV-2 infection in long COVID-19 |
Gyuntae Bae, Zhiqi Yang, Daniele Bucci, Claire Wegner, Hartmut Schäfer, Yogesh Singh, et al. (+2) Caterina Lonati, Christoph Trautwein |
| 4 |
[GO] |
2025―Apr―06 |
SARS-CoV2 variants differentially impact on the plasma metabolome |
Tina Kramaric, Onn Shaun Thein, Dhruv Parekh, Aaron Scott, Andrine Vangberg, Manfred Beckmann, et al. (+3) Helen Phillips, David Thickett, Luis A. J. Mur |
| 5 |
[GO] |
2024―Dez―05 |
Untargeted metabolomics and lipidomics in COVID-19 patient plasma reveals disease severity biomarkers |
Jinchun Sun, Megan Peters, Li-Rong Yu, Vikrant Vijay, Mallikarjun Bidarimath, Mona Agrawal, et al. (+6) Armando S. Flores-Torres, Amanda M. Green, Keith Burkhart, Jessica Oliphant, Heather S. Smallwood, Richard D. Beger |
| 6 |
[GO] |
2023―Okt―18 |
Quantitative LC-MS study of compounds found predictive of COVID-19 severity and outcome |
Ivayla Roberts, Marina Wright Muelas, Joseph M. Taylor, Andrew S. Davison, Catherine L. Winder, Royston Goodacre, Douglas B. Kell |
| 7 |
[GO] |
2023―Apr―15 |
Fetal effects of mild maternal COVID-19 infection: metabolomic profiling of cord blood |
Onur Turkoglu, Ali Alhousseini, Sonia Sajja, Jay Idler, Sean Stuart, Nadia Ashrafi, et al. (+4) Ali Yilmaz, Kurt Wharton, Stewart F. Graham, Ray O. Bahado-Singh |
| 8 |
[GO] |
2023―Jan―24 |
A metabolic readout of the urine metabolome of COVID-19 patients |
F. C. Marhuenda-Egea, J. Narro-Serrano, M. J. Shalabi-Benavent, J. M. Álamo-Marzo, C. Amador-Prous, J. T. Algado-Rabasa, et al. (+2) A. M. Garijo-Saiz, M. Marco-Escoto |
| 9 |
[GO] |
2022―Okt―22 |
Saliva metabolomic profile of COVID-19 patients associates with disease severity |
Narjes Saheb Sharif-Askari, Nelson Cruz Soares, Hajer A. Mohamed, Fatemeh Saheb Sharif-Askari, Hawra Ali Hussain Alsayed, Hamza Al-Hroub, et al. (+6) Laila Salameh, Rufaida Satti Osman, Bassam Mahboub, Qutayba Hamid, Mohammad H. Semreen, Rabih Halwani |
| 10 |
[GO] |
2022―Jul―12 |
Leveraging metabolic modeling to identify functional metabolic alterations associated with COVID-19 disease severity |
L. R. Dillard, N. Wase, G. Ramakrishnan, J. J. Park, N. E. Sherman, R. Carpenter, et al. (+4) M. Young, A. N. Donlan, W. Petri, J. A. Papin |
| 11 |
[GO] |
2021―Dez―20 |
Untargeted metabolomics of COVID-19 patient serum reveals potential prognostic markers of both severity and outcome |
Ivayla Roberts, Marina Wright Muelas, Joseph M. Taylor, Andrew S. Davison, Yun Xu, Justine M. Grixti, et al. (+4) Nigel Gotts, Anatolii Sorokin, Royston Goodacre, Douglas B. Kell |
|
